557 related articles for article (PubMed ID: 23879960)
1. Inflammatory cytokines in human pancreatic cancer.
Roshani R; McCarthy F; Hagemann T
Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
[TBL] [Abstract][Full Text] [Related]
2. Chronic pancreatitis: a path to pancreatic cancer.
Pinho AV; Chantrill L; Rooman I
Cancer Lett; 2014 Apr; 345(2):203-9. PubMed ID: 23981573
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6: a villain in the drama of pancreatic cancer development and progression.
Holmer R; Goumas FA; Waetzig GH; Rose-John S; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):371-80. PubMed ID: 25100121
[TBL] [Abstract][Full Text] [Related]
4. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and pancreatic ductal adenocarcinoma.
Habtezion A; Edderkaoui M; Pandol SJ
Cancer Lett; 2016 Oct; 381(1):211-6. PubMed ID: 26708507
[TBL] [Abstract][Full Text] [Related]
6. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
7. The immune network in pancreatic cancer development and progression.
Wörmann SM; Diakopoulos KN; Lesina M; Algül H
Oncogene; 2014 Jun; 33(23):2956-67. PubMed ID: 23851493
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
[TBL] [Abstract][Full Text] [Related]
9. Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.
Saif MW
JOP; 2010 Jul; 11(4):403-4; author reply 411. PubMed ID: 20601821
[No Abstract] [Full Text] [Related]
10. Exploiting inflammation for therapeutic gain in pancreatic cancer.
Steele CW; Jamieson NB; Evans TR; McKay CJ; Sansom OJ; Morton JP; Carter CR
Br J Cancer; 2013 Mar; 108(5):997-1003. PubMed ID: 23385734
[TBL] [Abstract][Full Text] [Related]
11. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
[TBL] [Abstract][Full Text] [Related]
12. Targeting both tumour-associated CXCR2
Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
14. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
15. The role of inflammation in pancreatic cancer.
Hausmann S; Kong B; Michalski C; Erkan M; Friess H
Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.
Hernández-Muñoz I; Skoudy A; Real FX; Navarro P
Pancreatology; 2008; 8(4-5):462-9. PubMed ID: 18724072
[TBL] [Abstract][Full Text] [Related]
17. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
Padoan A; Plebani M; Basso D
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
García-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival.
Delitto D; Black BS; Sorenson HL; Knowlton AE; Thomas RM; Sarosi GA; Moldawer LL; Behrns KE; Liu C; George TJ; Trevino JG; Wallet SM; Hughes SJ
BMC Cancer; 2015 Oct; 15():783. PubMed ID: 26498838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
